Associated Papers
Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients.
Sai K et al.
Cancer Chemotherapy and Pharmacology, 2010
Substrate-dependent effects of human ABCB1 coding polymorphisms.
Gow JM et al.
The Journal of Pharmacology and Experimental Therapeutics, 2008
Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan.
Sai K et al.
Pharmacogenetics, 2003
Select a paper to view details